News
News and presentations
Press releases, conference data and company news since our founding in 2019.
Scientific presentations
-
Scientific presentations
TCX-201 and TCX-101 data presented at AACR 2026
Two posters at the AACR Annual Meeting 2026 in San Diego: the preclinical profile of first clinical candidate TCX-201 (Poster 5631) and TCX-101 as a trispecific T-cell engager (Poster 5584).
-
Scientific presentations
TCX-201 poster at PEGS Europe 2025 in Lisbon
Poster A116 on TCX-201 at the Protein & Antibody Engineering Summit, November 11–13, 2025.
-
Scientific presentations
Talk at PEGS Boston 2025: targeting TACAs with high-affinity antibodies
Dr. Peter Sondermann speaks in the oncology stream of the Protein & Antibody Engineering Summit on May 14, 2025.
-
Scientific presentations
Two TACA antibodies, two modes of action: TCX-201 and TCX-101 at AACR 2025
Poster 1581 in Chicago: TCX-201 as an ADC against a fast-internalizing TACA, TCX-101 as a T-cell engager against a slow-internalizing one.
-
Scientific presentations
Two posters at the EORTC-NCI-AACR Symposium 2024
Dr. Wiebke Winkler and Dr. Gustavo Schmidt Moreira present Tacalyx data at ENA 2024 in Barcelona, October 23–25.
-
Scientific presentations
TCX-101 preclinical data presented at AACR 2024
Poster 3125: TCX-101, a novel antibody-drug conjugate targeting a tumor-associated carbohydrate antigen for the treatment of solid tumors.
Media inquiries: contact